Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer

Krushna C. Patra, Qi Wang, Prashanth T. Bhaskar, Luke Miller, Zebin Wang, Will Wheaton, Navdeep Chandel, Markku Laakso, William J. Muller, Eric L. Allen, Abhishek K. Jha, Gromoslaw A. Smolen, Michelle F. Clasquin, R. Brooks Robey, Nissim Hay*

*Corresponding author for this work

Research output: Contribution to journalArticle

278 Citations (Scopus)

Abstract

Accelerated glucose metabolism is a common feature of cancer cells. Hexokinases catalyze the first committed step of glucose metabolism. Hexokinase 2 (HK2) is expressed at high level in cancer cells, but only in a limited number of normal adult tissues. Using Hk2 conditional knockout mice, we showed that HK2 is required for tumor initiation and maintenance in mouse models of KRas-driven lung cancer, and ErbB2-driven breast cancer, despite continued HK1 expression. Similarly, HK2 ablation inhibits the neoplastic phenotype of human lung and breast cancer cells invitro and invivo. Systemic Hk2 deletion is therapeutic in mice bearing lung tumors without adverse physiological consequences. Hk2 deletion in lung cancer cells suppressed glucose-derived ribonucleotides and impaired glutamine-derived carbon utilization in anaplerosis.

Original languageEnglish (US)
Pages (from-to)213-228
Number of pages16
JournalCancer Cell
Volume24
Issue number2
DOIs
StatePublished - Aug 12 2013

Fingerprint

Hexokinase
Maintenance
Lung Neoplasms
Glucose
Neoplasms
Breast Neoplasms
Ribonucleotides
Therapeutics
Glutamine
Knockout Mice
Carbon
Phenotype
Lung

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Patra, Krushna C. ; Wang, Qi ; Bhaskar, Prashanth T. ; Miller, Luke ; Wang, Zebin ; Wheaton, Will ; Chandel, Navdeep ; Laakso, Markku ; Muller, William J. ; Allen, Eric L. ; Jha, Abhishek K. ; Smolen, Gromoslaw A. ; Clasquin, Michelle F. ; Robey, R. Brooks ; Hay, Nissim. / Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. In: Cancer Cell. 2013 ; Vol. 24, No. 2. pp. 213-228.
@article{c810e4140c6a4b88953e05642910fe7b,
title = "Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer",
abstract = "Accelerated glucose metabolism is a common feature of cancer cells. Hexokinases catalyze the first committed step of glucose metabolism. Hexokinase 2 (HK2) is expressed at high level in cancer cells, but only in a limited number of normal adult tissues. Using Hk2 conditional knockout mice, we showed that HK2 is required for tumor initiation and maintenance in mouse models of KRas-driven lung cancer, and ErbB2-driven breast cancer, despite continued HK1 expression. Similarly, HK2 ablation inhibits the neoplastic phenotype of human lung and breast cancer cells invitro and invivo. Systemic Hk2 deletion is therapeutic in mice bearing lung tumors without adverse physiological consequences. Hk2 deletion in lung cancer cells suppressed glucose-derived ribonucleotides and impaired glutamine-derived carbon utilization in anaplerosis.",
author = "Patra, {Krushna C.} and Qi Wang and Bhaskar, {Prashanth T.} and Luke Miller and Zebin Wang and Will Wheaton and Navdeep Chandel and Markku Laakso and Muller, {William J.} and Allen, {Eric L.} and Jha, {Abhishek K.} and Smolen, {Gromoslaw A.} and Clasquin, {Michelle F.} and Robey, {R. Brooks} and Nissim Hay",
year = "2013",
month = "8",
day = "12",
doi = "10.1016/j.ccr.2013.06.014",
language = "English (US)",
volume = "24",
pages = "213--228",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "2",

}

Patra, KC, Wang, Q, Bhaskar, PT, Miller, L, Wang, Z, Wheaton, W, Chandel, N, Laakso, M, Muller, WJ, Allen, EL, Jha, AK, Smolen, GA, Clasquin, MF, Robey, RB & Hay, N 2013, 'Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer', Cancer Cell, vol. 24, no. 2, pp. 213-228. https://doi.org/10.1016/j.ccr.2013.06.014

Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. / Patra, Krushna C.; Wang, Qi; Bhaskar, Prashanth T.; Miller, Luke; Wang, Zebin; Wheaton, Will; Chandel, Navdeep; Laakso, Markku; Muller, William J.; Allen, Eric L.; Jha, Abhishek K.; Smolen, Gromoslaw A.; Clasquin, Michelle F.; Robey, R. Brooks; Hay, Nissim.

In: Cancer Cell, Vol. 24, No. 2, 12.08.2013, p. 213-228.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer

AU - Patra, Krushna C.

AU - Wang, Qi

AU - Bhaskar, Prashanth T.

AU - Miller, Luke

AU - Wang, Zebin

AU - Wheaton, Will

AU - Chandel, Navdeep

AU - Laakso, Markku

AU - Muller, William J.

AU - Allen, Eric L.

AU - Jha, Abhishek K.

AU - Smolen, Gromoslaw A.

AU - Clasquin, Michelle F.

AU - Robey, R. Brooks

AU - Hay, Nissim

PY - 2013/8/12

Y1 - 2013/8/12

N2 - Accelerated glucose metabolism is a common feature of cancer cells. Hexokinases catalyze the first committed step of glucose metabolism. Hexokinase 2 (HK2) is expressed at high level in cancer cells, but only in a limited number of normal adult tissues. Using Hk2 conditional knockout mice, we showed that HK2 is required for tumor initiation and maintenance in mouse models of KRas-driven lung cancer, and ErbB2-driven breast cancer, despite continued HK1 expression. Similarly, HK2 ablation inhibits the neoplastic phenotype of human lung and breast cancer cells invitro and invivo. Systemic Hk2 deletion is therapeutic in mice bearing lung tumors without adverse physiological consequences. Hk2 deletion in lung cancer cells suppressed glucose-derived ribonucleotides and impaired glutamine-derived carbon utilization in anaplerosis.

AB - Accelerated glucose metabolism is a common feature of cancer cells. Hexokinases catalyze the first committed step of glucose metabolism. Hexokinase 2 (HK2) is expressed at high level in cancer cells, but only in a limited number of normal adult tissues. Using Hk2 conditional knockout mice, we showed that HK2 is required for tumor initiation and maintenance in mouse models of KRas-driven lung cancer, and ErbB2-driven breast cancer, despite continued HK1 expression. Similarly, HK2 ablation inhibits the neoplastic phenotype of human lung and breast cancer cells invitro and invivo. Systemic Hk2 deletion is therapeutic in mice bearing lung tumors without adverse physiological consequences. Hk2 deletion in lung cancer cells suppressed glucose-derived ribonucleotides and impaired glutamine-derived carbon utilization in anaplerosis.

UR - http://www.scopus.com/inward/record.url?scp=84881557242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881557242&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2013.06.014

DO - 10.1016/j.ccr.2013.06.014

M3 - Article

VL - 24

SP - 213

EP - 228

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 2

ER -